Trial Details
TERMINATEDBasic Information
| Clinical ID | c1802 |
|---|---|
| Identifier | NCT04456517 |
| Trial Title | Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease|Inflammatory Bowel Disease |
| Interventions | DRUG: Ranolazine|DRUG: Placebo |
Participant Information
| Sponsor | Vanderbilt University Medical Center |
|---|---|
| City | Nashville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-10-18 |
|---|---|
| Primary Completion Date | 2024-04-11 |
| Completion Date | 2024-04-11 |